Four years monitorization of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics;Yoǧun bakιm ve servis hastalarιndan izole edilen Pseudomonas aeruginosa ve Acinetobacter baumannii izolatlarιnιn antibiyotik duyarlιlιk oranlarιnιn dört yιllιk izlemi

Mikrobiyoloji Bulteni

Volumn 42, Issue 2, 2008, Pages 321-329

  Alişkan, Hikmet ^a   Çolakoǧlu, Şule ^a   Turunç, Tuba ^a   Demiroǧlu, Yusuf Ziya ^a   Erdoǧan, Ferit ^a   Akin, Şule ^a   Arslan, Hande ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Inpatient clinics; Intensive care units; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; CROSS INFECTION; DRUG EFFECT; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 52349112038     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kollef MH. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis. 2006; 43 (Suppl 2): 82-8.
2. Ferrara AM. Potentially multidrug-resistant non-fermentative gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents 2006; 27:183-95.
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement. CLSI/NCCLS Document M100-S15. 2005, Wayne, Pa.
4. Paterson DL. Serious infections in the intensive care unit: Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 2006; 43: S41-2.
5. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
6. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148-65.
7. Ortega B, Groeneveld AB, Schultsz C. Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Infect Control Hosp Epidemiol 2004; 25: 825-31.
8. Defez C, Fabbro-Peray P, Bouziges N, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect 2004; 57: 209-16.
9. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000; 31: 690-7.
10. Nouer SA, Nucci M, de-Oliveira MP, Pellegrino FL, Moreira BM. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob Agents Chemother 2005; 49: 3663-7.
11. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 (Suppl 2): S43-8.
12. Makedou KG. Changes in antibiotic resistance of the most common gram-negative bacteria isolated in intensive care units. J Hosp Infect 2005; 60: 245-8.
13. Turner PJ. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002). Diagn Microbiol Infect Dis 2005; 51: 281-9.
14. Goossens H. Susceptibility of multidrug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group. Clin Microbiol Infect 2003; 9: 980-3.
15. Gunseren F, Mamikoglu L, Ozturk S, et al. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 1999; 43: 373-8.
16. Küçükateş E. Antimicrobial resistance among gram-negative bacteria isolated from intensive care units in a Cardiology Institute in Istanbul, Turkey. Jpn J Infect Dis 2005; 58: 228-31.
17. Aktaş O, Ozbek A. Prevalence and in-vitro antimicrobial susceptibility patterns of Acinetobacter strains isolated from patients in intensive care units. J Int Med Res 2003; 31: 272-80.
18. Kilic A, Kucukkaraaslan A, Senses Z, Baysallar M, Doganci L. Investigation of the in-vitro effectiveness of ertapenem against Pseudomonas aeruginosa strains isolated from intensive care unit patients. Mikrobiyol Bul 2004; 38: 355-62.
19. Akan OA. Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002. Mikrobiyol Bul 2003; 37: 241-6.
20. Zarakolu P, Hasçelik G, Ünal S. Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004). Mikrobiyol Bul 2006; 40: 147-54.
21. Ulutaş E, Onurdaǧ FK, Abbasoǧlu U, Sultan N, Gürcan IS. Klinik örneklerden izole edilen Pseudomonas suşlannin antibiyotilklere duyarliliklari. Türk Mikrobiyol Cem Derg 2006; 36: 140-9.
22. Raymond DP, Pelletier SJ, Srabtree TD, et al. Impact of rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001; 29: 1101-8.